Reuters US Business

US SEC would set up guardrails for private investments in retirement plans, chairman says

NEW YORK -The U.S. Securities and Exchange Commission is prepared to work with the Labor Department to establish guardrails for investors if they gain greater access to private markets in retirement plans, the agency’s chief said in a CNBC interview on Monday. “We can work with the Department of Labor to help to have good …

US SEC would set up guardrails for private investments in retirement plans, chairman says Read More »

Ether Machine, backed by crypto giants, set to raise over $1.6 billion in Nasdaq debut

By Ateev Bhandari (Reuters) -The Ether Reserve, a new crypto venture backed by prominent crypto investors, will list on the Nasdaq through a merger with blank-check firm Dynamix Corporation and is expected to raise over $1.6 billion. The combined entity, to be named The Ether Machine, aims to launch with more than 400,000 Ether on …

Ether Machine, backed by crypto giants, set to raise over $1.6 billion in Nasdaq debut Read More »

Crypto-linked stocks advance after Trump signs stablecoin law

By Shashwat Chauhan (Reuters) -Shares of crypto-linked companies jumped on Monday, as ether prices scaled their highest this year after President Donald Trump signed into law a bill regulating stablecoins in the U.S. Trump signed the GENIUS Act late on Friday, marking a huge win for crypto industry that has been lobbying for a regulatory …

Crypto-linked stocks advance after Trump signs stablecoin law Read More »

Figma aims at $16.4 billion valuation as tech IPOs bounce back

By Niket Nishant (Reuters) -Figma is targeting a fully-diluted valuation of up to $16.4 billion in its initial public offering, as the cloud-based design software firm prepares for a debut on the NYSE that could inject fresh momentum into a resurgent market for tech listings. The San Francisco-based company, along with some investors, is eyeing …

Figma aims at $16.4 billion valuation as tech IPOs bounce back Read More »

Bank of Canada survey: firms less worried by worst-case tariff scenarios

By Promit Mukherjee and David Ljunggren OTTAWA, July 21 (Reuters) – Canadian businesses see less chance of a worst-case tariffs scenario but remain cautious and are keeping hiring and investment under check, the Bank of Canada said in a regular quarterly survey on Monday. Firms’ short-term inflation expectations have returned to levels observed at the …

Bank of Canada survey: firms less worried by worst-case tariff scenarios Read More »

Block rises on S&P 500 inclusion, signaling fintech’s growing clout

By Manya Saini (Reuters) -Tech billionaire Jack Dorsey-led Block’s shares rose 7% in morning trading on Monday after the payments firm was added to the benchmark S&P 500, marking a milestone for the fintech sector. The inclusion cements Block’s status as one of the most valuable and influential players in the fintech space, and shows …

Block rises on S&P 500 inclusion, signaling fintech’s growing clout Read More »

Brazil acknowledges possibility of no US trade deal by August 1

SAO PAULO (Reuters) -Brazil’s finance minister said on Monday his country would not give up negotiating with the U.S. but acknowledged that a trade deal may fail to be reached by August 1, when President Donald Trump’s 50% tariffs on Brazilian goods are due to take effect. “That could happen,” Fernando Haddad told radio station …

Brazil acknowledges possibility of no US trade deal by August 1 Read More »

Flexjet valued at $4 billion after securing funding from LVMH-backed private equity firm

(Reuters) -Flexjet said on Monday it had raised $800 million in a funding round led by L Catterton, a private equity firm backed by LVMH, valuing the U.S. jet operator at $4 billion just a couple of years after a botched deal with Todd Boehly’s SPAC. The funding comes as more companies remain private, seeking …

Flexjet valued at $4 billion after securing funding from LVMH-backed private equity firm Read More »

Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm

(Reuters) -Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump’s tariff threats. Biogen joins major drugmakers such as Eli  Lilly, Roche and Merck, who have all announced investments in the U.S. as the …

Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm Read More »

Close Bitnami banner
Bitnami